Home / ENDV : OTC

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does ENDV make money? Does ENDV have pricing power? What's the Earnings Whisper? Will ENDV profit more as the business scales? What is ENDV's management track record? Is ENDV's current price justified?

Endonovo Therapeutics, Inc.

$0 +$0.00 (+0.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0 - $0

Year Range

$0$0

Market Cap

31.88K

AVG Volume

654.08K

Trailing/Forward PE

-0.2/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD) · TTM

ENDV Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	1.66K
24 Q4	10.04K
24 Q3	16.02K
24 Q2	17.55K
24 Q1	61.08K

Net Income (USD) · TTM

ENDV Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-2.26M
26 Q1	-2.23M
25 Q4	-2.18M
25 Q3	-2.3M
25 Q2	-2.46M
25 Q1	-2.62M
24 Q4	-2.8M
24 Q3	-3.73M
24 Q2	-3.8M
24 Q1	-1.02M

Operating Income (USD) · TTM

ENDV Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-1.02M
26 Q1	-992.27K
25 Q4	-945.77K
25 Q3	-1.07M
25 Q2	-1.23M
25 Q1	-1.39M
24 Q4	-1.56M
24 Q3	-1.99M
24 Q2	-2.07M
24 Q1	-2.79M

EBITDA (USD) · TTM

ENDV EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-1.02M
26 Q1	-992.27K
25 Q4	-938.77K
25 Q3	-933.94K
25 Q2	-925.06K
25 Q1	-926.73K
24 Q4	-941.4K
24 Q3	-1.78M
24 Q2	-1.87M
24 Q1	913.88K

Cash Flows (USD) · TTM

ENDV Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-117.42K
24 Q4	100.48K
24 Q3	523.96K
24 Q2	459.7K
24 Q1	292.82K
23 Q4	121.87K
23 Q3	-629.9K
23 Q2	-688.4K
23 Q1	-729.04K
22 Q4	-678.84K

EPS (USD) · TTM

ENDV EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	0
26 Q1	0
25 Q4	-0
25 Q3	-0
25 Q2	-0
25 Q1	-0
24 Q4	-0.01
24 Q3	-0.01
24 Q2	-0.01
24 Q1	-0

Expenses (USD) · TTM

ENDV Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
23 Q4	3
23 Q3	0
23 Q2	0
23 Q1	0
22 Q4	0
26 Q2	1.02M
26 Q1	743.71K
25 Q4	697.2K
25 Q3	530.65K
25 Q2	521.77K
25 Q1	771.74K
24 Q4	783.01K
24 Q3	1.35M
24 Q2	1.43M
24 Q1	2.2M

Shares Outstanding · TTM

ENDV Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	0
24 Q4	0
24 Q3	-485.78K
24 Q2	-120.25K
24 Q1	-741.09K
23 Q4	-741.09K
23 Q3	-300.31K
23 Q2	-665.85K
23 Q1	-45K
22 Q4	-196.05K

Employee Count

ENDV Employee Count by quarter
Period	Employee Count
2019	10
2018	10
2017	15
2016	10
2015	10
2014	10
2013	17
2012	14
2011	6

PE Ratio

ENDV PE Ratio by quarter
Period	PE Ratio
Jun 24	0.05
Jun 24	0.07
Jun 24	0.04
Jun 24	0.05
May 24	0.05
May 24	0.06
May 24	0.05
May 24	0.07
May 24	0.12
Apr 24	0.12
Apr 24	0.12
Apr 24	0.12
Apr 24	0.15

Free Cash Flow Yield

ENDV Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Jun 25	92.38%
Jun 25	92.38%
Jun 25	92.38%
Jun 25	123.17%
May 25	184.76%
May 25	184.76%
May 25	92.38%
May 25	123.17%
May 25	184.76%
Apr 25	92.38%
Apr 25	73.9%
Apr 25	61.59%
Apr 25	92.38%
Mar 25	963.39%
Mar 25	642.26%
Mar 25	642.26%
Mar 25	481.69%
Feb 25	481.69%
Feb 25	963.39%
Feb 25	481.69%
Feb 25	321.13%
Jan 25	321.13%
Jan 25	385.35%
Jan 25	240.85%
Jan 25	240.85%
Jan 25	120.42%
Dec 24	289.66%
Dec 24	289.66%
Dec 24	165.52%
Dec 24	165.52%
Nov 24	165.52%
Nov 24	165.52%
Nov 24	128.74%
Nov 24	115.87%
Nov 24	112.49%
Oct 24	115.87%
Oct 24	128.74%
Oct 24	128.74%
Oct 24	128.74%
Sep 24	46.82%
Sep 24	41.8%
Sep 24	33.44%
Sep 24	42.56%
Aug 24	33.44%
Aug 24	31.21%
Aug 24	48.77%
Aug 24	43.96%
Aug 24	40.71%
Jul 24	39.02%
Jul 24	39.02%
Jul 24	46.82%
Jul 24	52.02%
Jun 24	36.41%
Jun 24	25.49%
Jun 24	47.79%
Jun 24	38.23%
May 24	34.76%
May 24	29.41%
May 24	33.54%
May 24	25.49%
May 24	15.29%
Apr 24	14.54%
Apr 24	14.59%
Apr 24	14.16%
Apr 24	11.95%
Mar 24	-68.1%
Mar 24	-62.09%
Mar 24	-60.31%
Mar 24	-51.49%
Mar 24	-63.97%
Feb 24	-58.64%
Feb 24	-53.31%
Feb 24	-63.97%
Feb 24	-35.18%
Jan 24	-34.05%
Jan 24	-23.72%
Jan 24	-21.65%
Jan 24	-24.84%
Dec 23	-24.26%
Dec 23	-24.19%
Dec 23	-27.38%
Dec 23	-22.65%
Dec 23	-20.76%
Nov 23	-19.16%
Nov 23	-21.91%
Nov 23	-20.25%
Nov 23	-19.87%
Oct 23	-19.16%
Oct 23	-17.92%
Oct 23	-24.19%
Oct 23	-21.48%
Sep 23	-19.77%
Sep 23	-19.77%
Sep 23	-22.42%
Sep 23	-20.76%
Sep 23	-19.62%
Aug 23	-24.67%
Aug 23	-28.72%
Aug 23	-29%
Aug 23	-26.37%

Price to Sales

ENDV Price to Sales by quarter
Period	Price to Sales
Sep 25	66.1
Sep 25	66.1
Sep 25	66.1
Sep 25	66.1
Aug 25	66.1
Aug 25	66.1
Aug 25	132.2
Aug 25	66.1
Aug 25	132.2
Jul 25	132.2
Jul 25	132.2
Jul 25	118.98
Jul 25	66.1
Jun 25	10.83
Jun 25	10.83
Jun 25	10.83
Jun 25	8.12
May 25	5.42
May 25	5.42
May 25	10.83
May 25	8.12
May 25	5.42
Apr 25	10.83
Apr 25	13.54
Apr 25	16.25
Apr 25	10.83
Mar 25	3.39
Mar 25	5.09
Mar 25	5.09
Mar 25	6.79
Feb 25	6.79
Feb 25	3.39
Feb 25	6.79
Feb 25	10.18
Jan 25	10.18
Jan 25	8.48
Jan 25	13.58
Jan 25	13.58
Jan 25	27.15
Dec 24	9.05
Dec 24	9.05
Dec 24	15.83
Dec 24	15.83
Nov 24	15.83
Nov 24	15.83
Nov 24	20.35
Nov 24	22.61
Nov 24	23.29
Oct 24	22.61
Oct 24	20.35
Oct 24	20.35
Oct 24	20.35
Sep 24	10.24
Sep 24	11.47
Sep 24	14.33
Sep 24	11.26
Aug 24	14.33
Aug 24	15.36
Aug 24	9.83
Aug 24	10.9
Aug 24	11.77
Jul 24	12.29
Jul 24	12.29
Jul 24	10.24
Jul 24	9.21
Jun 24	2.39
Jun 24	3.41
Jun 24	1.82
Jun 24	2.27
May 24	2.5
May 24	2.95
May 24	2.59
May 24	3.41
May 24	5.68
Apr 24	5.98
Apr 24	5.95
Apr 24	6.14
Apr 24	7.27
Mar 24	3.62
Mar 24	3.97
Mar 24	4.08
Mar 24	4.78
Mar 24	3.85
Feb 24	4.2
Feb 24	4.62
Feb 24	3.85
Feb 24	7
Jan 24	7.23
Jan 24	10.39
Jan 24	11.38
Jan 24	9.92
Dec 23	10.15
Dec 23	10.73
Dec 23	9.48
Dec 23	11.46
Dec 23	12.51
Nov 23	13.55
Nov 23	11.85
Nov 23	12.82
Nov 23	13.06

EV/EBITDA

ENDV EV/EBITDA by quarter
Period	EV/EBITDA
Sep 24	8.41
Sep 24	8.49
Sep 24	8.68
Sep 24	8.48
Aug 24	8.68
Aug 24	8.75
Aug 24	8.38
Aug 24	8.45
Aug 24	8.51
Jul 24	8.54
Jul 24	8.54
Jul 24	8.41
Jul 24	8.34
Jun 24	0.84
Jun 24	0.85
Jun 24	0.83
Jun 24	0.83
May 24	0.84
May 24	0.85
May 24	0.84
May 24	0.85
May 24	0.89
Apr 24	0.89
Apr 24	0.89
Apr 24	0.9
Apr 24	0.91
May 21	3.06
May 21	3.09
May 21	3.09
Apr 21	3.12
Apr 21	3.07
Apr 21	3.04
Apr 21	16.82
Apr 21	16.78
Mar 21	16.95
Mar 21	17.19
Mar 21	17.32
Mar 21	16.7
Feb 21	16.95
Feb 21	18.38
Feb 21	18.63
Feb 21	17.46
Jan 21	17.48
Jan 21	17.09
Jan 21	17.55
Jan 21	16.91
Dec 20	16.33
Dec 20	16.83
Dec 20	16.74
Dec 20	16.9
Dec 20	16.54
Nov 20	17.72
Nov 20	18.21
Nov 20	15.36
Nov 20	15.71
Oct 20	15.88
Oct 20	15.65
Oct 20	15.49
Oct 20	15.68
Oct 20	15.84
Sep 20	16.14
Sep 20	16.19
Sep 20	16.14
Sep 20	16.04
Aug 20	16.14
Aug 20	16.29

Price/Operating Cashflow

ENDV Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Jun 25	1.08
Jun 25	1.08
Jun 25	1.08
Jun 25	0.81
May 25	0.54
May 25	0.54
May 25	1.08
May 25	0.81
May 25	0.54
Apr 25	1.08
Apr 25	1.35
Apr 25	1.62
Apr 25	1.08
Mar 25	0.1
Mar 25	0.16
Mar 25	0.16
Mar 25	0.21
Feb 25	0.21
Feb 25	0.1
Feb 25	0.21
Feb 25	0.31
Jan 25	0.31
Jan 25	0.26
Jan 25	0.42
Jan 25	0.42
Jan 25	0.83
Dec 24	0.35
Dec 24	0.35
Dec 24	0.6
Dec 24	0.6
Nov 24	0.6
Nov 24	0.6
Nov 24	0.78
Nov 24	0.86
Nov 24	0.89
Oct 24	0.86
Oct 24	0.78
Oct 24	0.78
Oct 24	0.78
Sep 24	2.14
Sep 24	2.39
Sep 24	2.99
Sep 24	2.35
Aug 24	2.99
Aug 24	3.2
Aug 24	2.05
Aug 24	2.27
Aug 24	2.46
Jul 24	2.56
Jul 24	2.56
Jul 24	2.14
Jul 24	1.92
Jun 24	2.75
Jun 24	3.92
Jun 24	2.09
Jun 24	2.62
May 24	2.88
May 24	3.4
May 24	2.98
May 24	3.92
May 24	6.54
Apr 24	6.88
Apr 24	6.85
Apr 24	7.06
Apr 24	8.37

No video analysis for this stock yet. Request one from our team.

AI Analysis

Endonovo Therapeutics, Inc.

Video analysis: ENDV

Similar companies